Literature DB >> 13820025

Further studies in achalasia of the cardia.

F G ELLIS, R KAUNTZE, A NIGHTINGALE, J R TROUNCE.   

Abstract

Entities:  

Keywords:  CARDIOSPASM/physiology

Mesh:

Year:  1960        PMID: 13820025

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


× No keyword cloud information.
  10 in total

1.  The intrinsic innervation of the human alimentary tract and its relation to function.

Authors:  A Bennett; H L Stockley
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

2.  The aetiology and treatment of achalasia of the cardia.

Authors:  F G ELLIS
Journal:  Ann R Coll Surg Engl       Date:  1962-03       Impact factor: 1.891

3.  Clinical implications of recent advances in the physiology of motility and absorption.

Authors:  E N ROWLANDS
Journal:  Proc R Soc Med       Date:  1961-09

4.  Effects of postganglionic nerve stimulation in oesophageal achalasia: an in vitro study.

Authors:  A Tłottrup; A Forman; P Funch-Jensen; U Raundahl; K E Andersson
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

5.  A pharmacological investigation of human isolated stomach.

Authors:  A Bennett; B Whitney
Journal:  Br J Pharmacol Chemother       Date:  1966-08

6.  Inco-ordination of oesophageal motor activity.

Authors:  M Atkinson
Journal:  Postgrad Med J       Date:  1968-08       Impact factor: 2.401

7.  The application of motility studies to gastroenterological problems.

Authors:  J J Misiewicz
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

8.  A pharmacological study of the motility of the human gastrointestinal tract.

Authors:  A Bennett; B Whitney
Journal:  Gut       Date:  1966-08       Impact factor: 23.059

9.  A PRELIMINARY INVESTIGATION OF THE PHARMACOLOGY OF THE HUMAN ISOLATED TAENIA COLI PREPARATION.

Authors:  A BUCKNELL; B WHITNEY
Journal:  Br J Pharmacol Chemother       Date:  1964-08

10.  Achalasia in Anderson-Fabry's disease.

Authors:  D H Roberts; I T Gilmore
Journal:  J R Soc Med       Date:  1984-05       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.